Fluvoxamine for the treatment of COVID-19

Marzolini, Catia ORCID: 0000-0002-2312-7050, Marra, Fiona, Boyle, Alison, Khoo, Saye ORCID: 0000-0002-2769-0967 and Back, David J (2022) Fluvoxamine for the treatment of COVID-19. LANCET GLOBAL HEALTH, 10 (3). E331-E331. ISSN 2214-109X, 2214-109X

Access the full-text of this item by clicking on the Open Access link.

Official URL: https://doi.org/10.1016/s2214-109x(21)00592-1

Item Type:	Article
Uncontrolled Keywords:	Humans, Fluvoxamine, SARS-CoV-2, COVID-19 Drug Treatment
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	07 Mar 2022 08:42
Last Modified:	07 Dec 2024 23:23
DOI:	10.1016/s2214-109x(21)00592-1
Open Access URL:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88466...
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3150203